Haemonetics Corp. HAE

NYS: HAE | ISIN: US4050241003 7/04/2026

59,56 USD (+1,88%)

(+1,88%) 7/04/2026

Grafiek Haemonetics Corp.

Grafiek Haemonetics Corp.

1 dag1d 1,88%
1 week1w 5,90%
1 maand1m -7,27%
3 maanden3m -29,13%
6 maanden6m 16,83%
1 jaar1j 6,28%
5 jaar5j -47,65%

Haemonetics Corp. in het nieuws

Toon enkel gratis nieuws

1 april 2026 · Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026 · Persbericht

30 maart 2026 · Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System · Persbericht

23 februari 2026 · Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology · Persbericht

20 februari 2026 · Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference · Persbericht

5 februari 2026 · Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website · Persbericht

9 januari 2026 · Haemonetics Acquires Vivasure Medical Limited · Persbericht

8 januari 2026 · Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2026 Results: February 5, 2026 · Persbericht

2 januari 2026 · Haemonetics to Present at 44th Annual J.P. Morgan Healthcare Conference · Persbericht

6 november 2025 · Haemonetics Corporation Announces Second Quarter Fiscal 2026 Financial Results Available on Investor Relations Website · Persbericht

9 oktober 2025 · Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2026 Results: November 6, 2025 · Persbericht

Profiel Haemonetics Corp.

Gezondheidstechnologie

Medische Specialiteiten

Productie van medische instrumenten

Website: www.haemonetics.com

Hoofdzetel: Boston, Massachusetts Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe